177
Views
20
CrossRef citations to date
0
Altmetric
Review

Novel pharmacotherapy for fibromyalgia

, &
Pages 829-841 | Published online: 15 May 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Yukinori Nagakura. (2015) Recent Advancements in Animal Models of Fibromyalgia. MYOPAIN 23:3-4, pages 104-111.
Read now
Masaaki Tanaka & Yasuyoshi Watanabe. (2012) Risk-management syndrome. International Journal of Psychiatry in Clinical Practice 16:4, pages 312-315.
Read now
Jacob N Ablin & Dan Buskila. (2008) Emerging therapies for fibromyalgia. Expert Opinion on Emerging Drugs 13:1, pages 53-62.
Read now

Articles from other publishers (17)

Lovedeep Singh, Anudeep Kaur, Amrit Pal Singh & Rajbir Bhatti. (2021) Daphnetin, a natural coumarin averts reserpine-induced fibromyalgia in mice: modulation of MAO-A. Experimental Brain Research 239:5, pages 1451-1463.
Crossref
Xianli Yao, Li Li, Amit Kandhare, Anwesha Mukherjee‑Kandhare & Subhash Bodhankar. (2019) Attenuation of reserpine‑induced fibromyalgia via ROS and serotonergic pathway modulation by fisetin, a plant flavonoid polyphenol. Experimental and Therapeutic Medicine.
Crossref
Justin N. Siemian, Li Shang, Robert W. Seaman, Qing Zhu, Yanan Zhang & Jun-Xu Li. (2019) Effects of imidazoline I2 receptor agonists on reserpine-induced hyperalgesia and depressive-like behavior in rats. Behavioural Pharmacology 30:5, pages 429-434.
Crossref
Atekeh Hadinezhad MakraniMahdi AfshariMarayam GhajarZahra ForooghiMahmood Moosazadeh. (2017) Vitamin D and fibromyalgia: a meta-analysis. The Korean Journal of Pain 30:4, pages 250.
Crossref
Ting-ting Zhang, Rui Xue, Lei Zhu, Juan Li, Qiong-yin Fan, Bo-hua Zhong, Yun-feng Li, Cai-ying Ye & You-zhi Zhang. (2016) Evaluation of the analgesic effects of ammoxetine, a novel potent serotonin and norepinephrine reuptake inhibitor. Acta Pharmacologica Sinica 37:9, pages 1154-1165.
Crossref
Yasuo Itomi, Yasuhiro Tsukimi & Toru Kawamura. (2016) Impaired diffuse noxious inhibitory controls in specific alternation of rhythm in temperature-stressed rats. European Journal of Pharmacology 784, pages 61-68.
Crossref
Cristina Frange, Camila Hirotsu, Helena Hachul, Paula Araujo, Sergio Tufik & Monica L. Andersen. (2014) Fibromyalgia and Sleep in Animal Models: A Current Overview and Future Directions. Current Pain and Headache Reports 18:8.
Crossref
Janice E. Sumpton & Dwight E. Moulin. 2014. Neurologic Aspects of Systemic Disease Part I. Neurologic Aspects of Systemic Disease Part I 513 527 .
Noha T. Abokrysha. (2012) Vitamin D Deficiency in Women with Fibromyalgia in Saudi Arabia. Pain Medicine 13:3, pages 452-458.
Crossref
Winfried Häuser, Frank Petzke & Claudia Sommer. (2010) Comparative Efficacy and Harms of Duloxetine, Milnacipran, and Pregabalin in Fibromyalgia Syndrome. The Journal of Pain 11:6, pages 505-521.
Crossref
Yukinori Nagakura, Tomoya Oe, Toshiaki Aoki & Nobuya Matsuoka. (2009) Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia. Pain 146:1, pages 26-33.
Crossref
Raphael J Leo. (2009) Milnacipran, a serotonin and norepinephrine reuptake inhibitor: a novel treatment for fibromyalgia. International Journal of Clinical Rheumatology 4:5, pages 507-517.
Crossref
Linda L. Krypel. (2008) Fibromyalgia: A Review of Its Pathophysiology and Drug Treatment. Journal of Pharmacy Practice 22:1, pages 6-16.
Crossref
Abouch V. Krymchantowski, Juline Bryson, Richard B. Lipton & Marcelo E. Bigal. (2008) Neuromodulators for the treatment of headache disorders and fibromyalgia. Current Pain and Headache Reports 12:5, pages 333-337.
Crossref
Victoria Menzies & Sunny Kim. (2008) Relaxation and Guided Imagery in Hispanic Persons Diagnosed With Fibromyalgia. Family & Community Health 31:3, pages 204-212.
Crossref
Diane T. Stephenson & Stephen P. Arneric. (2008) Neuroimaging of Pain: Advances and Future Prospects. The Journal of Pain 9:7, pages 567-579.
Crossref
Luca Scascighini & Haiko Sprott. (2008) Chronic nonmalignant pain: a challenge for patients and clinicians. Nature Clinical Practice Rheumatology 4:2, pages 74-81.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.